Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 66.11B | 56.21B | 63.72B | 62.20B | 66.47B | 71.50B |
Gross Profit | 61.42B | 0.00 | 63.72B | 62.20B | 66.47B | 71.50B |
EBITDA | 13.82B | 7.09B | 7.80B | 13.63B | 9.04B | 0.00 |
Net Income | 7.53B | 8.65B | 6.90B | 6.33B | 4.91B | 4.18B |
Balance Sheet | ||||||
Total Assets | 4.58T | 4.51T | 4.43T | 4.29T | 4.64T | 4.31T |
Cash, Cash Equivalents and Short-Term Investments | 500.63B | 0.00 | 432.51B | 347.34B | 903.76B | 535.49B |
Total Debt | 386.03B | 304.16B | 291.39B | 208.16B | 578.13B | 243.49B |
Total Liabilities | 4.37T | 4.30T | 4.22T | 208.16B | 4.41T | 4.07T |
Stockholders Equity | 210.13B | 205.97B | 213.11B | 194.66B | 229.30B | 238.11B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 39.80B | -8.74B | -384.83B | 369.63B | 261.97B |
Operating Cash Flow | 0.00 | 42.27B | -4.75B | -382.47B | 373.67B | 269.31B |
Investing Cash Flow | 0.00 | -102.27B | 23.39B | -143.94B | -5.05B | 52.87B |
Financing Cash Flow | 0.00 | 56.07B | 57.24B | -32.29B | -2.25B | 226.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥13.92T | 11.90 | 7.92% | 3.46% | 5.50% | 24.85% | |
78 Outperform | $583.62B | 11.86 | 4.55% | 4.83% | 7.20% | 31.52% | |
73 Outperform | ¥953.97B | 12.81 | 6.30% | 3.29% | 9.27% | 20.49% | |
72 Outperform | ¥78.84B | 9.11 | 4.16% | 10.31% | 19.79% | ||
67 Neutral | ¥713.17B | 10.66 | 7.55% | 3.34% | 7.97% | 15.90% |